| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3945242 | Gynecologic Oncology | 2012 | 6 Pages |
Abstract
⺠We investigated aflibercept as palliative treatment in advanced ovarian cancer with recurrent ascites. ⺠Aflibercept controlled ascites were tolerated; treatment-related grade 3/4 adverse events were infrequent. ⺠Aflibercept offers the potential to provide effective symptom relief in selected patients in this setting.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Nicoletta Colombo, Giorgia Mangili, Serafina Mammoliti, MÃ¥rten Kalling, Bengt Tholander, Lars Sternas, Giliane Buzenet, Donald Chamberlain,